Correlation Engine 2.0
Clear Search sequence regions


  • and diseases (1)
  • humans (1)
  • lipids (9)
  • lipogenesis (13)
  • liver (2)
  • liver disease (1)
  • Sizes of these terms reflect their relevance to your search.

    De novo lipogenesis (DNL) is a critical metabolic process that provides the majority of lipids for adipocyte and liver tissue. In cancer, obesity, type II diabetes, and nonalcoholic fatty liver disease DNL becomes dysregulated. A deeper understanding of the rates and of subcellular organization of DNL is necessary for identifying how this dysregulation occurs and varies across individuals and diseases. However, DNL is difficult to study inside the cell because labeling lipids and their precursors is not trivial. Existing techniques either can only measure parts of DNL, like glucose uptake, or do not provide spatiotemporal resolution. Here, we track DNL in space and time as isotopically labeled glucose is converted to lipids in adipocytes using optical photothermal infrared microscopy (OPTIR). OPTIR provides submicron resolution infrared imaging of the glucose metabolism in both living and fixed cells while also reporting on the identity of lipids and other biomolecules. We show significant incorporation of the labeled carbons into triglycerides in lipid droplets over the course of 72 h. Live cells had better preservation of lipid droplet morphology, but both showed similar DNL rates. Rates of DNL, as measured by the ratio of 13C-labeled lipid to 12C-labeled lipid, were heterogeneous, with differences within and between lipid droplets and from cell to cell. The high rates of DNL measured in adipocyte cells match upregulated rates of DNL previously reported in PANC1 pancreatic cancer cells. Taken together, our findings support a model where DNL is locally regulated to meet energy needs within cells.

    Citation

    Sydney O Shuster, Michael J Burke, Caitlin M Davis. Spatiotemporal Heterogeneity of De Novo Lipogenesis in Fixed and Living Single Cells. The journal of physical chemistry. B. 2023 Apr 06;127(13):2918-2926

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36976708

    View Full Text